Annual Cash & Cash Equivalents
$2.81 M
-$4.07 M-59.13%
01 December 2023
Summary:
Artelo Biosciences annual cash & cash equivalents is currently $2.81 million, with the most recent change of -$4.07 million (-59.13%) on 01 December 2023. During the last 3 years, it has fallen by -$9.35 million (-76.85%). ARTL annual cash & cash equivalents is now -76.85% below its all-time high of $12.16 million, reached on 01 December 2021.ARTL Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$4.36 M
+$3.48 M+394.55%
01 September 2024
Summary:
Artelo Biosciences quarterly cash and cash equivalents is currently $4.36 million, with the most recent change of +$3.48 million (+394.55%) on 01 September 2024. Over the past year, it has increased by +$1.54 million (+54.78%). ARTL quarterly cash and cash equivalents is now -68.98% below its all-time high of $14.05 million, reached on 30 November 2021.ARTL Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ARTL Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +54.8% |
| 3 y3 years | -76.8% | -64.2% |
| 5 y5 years | -36.4% | +29.1% |
ARTL Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -76.8% | at low | -64.2% | +394.6% |
| 5 y | 5 years | -76.8% | +31.4% | -69.0% | +394.6% |
| alltime | all time | -76.8% | >+9999.0% | -69.0% | >+9999.0% |
Artelo Biosciences Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.36 M(+394.6%) |
| June 2024 | - | $881.00 K(-26.3%) |
| Mar 2024 | - | $1.20 M(-57.5%) |
| Dec 2023 | $2.81 M(-59.1%) | $2.81 M(+6.7%) |
| Sept 2023 | - | $2.64 M(-53.9%) |
| June 2023 | - | $5.72 M(-17.3%) |
| Mar 2023 | - | $6.92 M(+0.4%) |
| Dec 2022 | $6.89 M(-43.4%) | $6.89 M(-3.5%) |
| Sept 2022 | - | $7.14 M(-41.1%) |
| June 2022 | - | $12.12 M(+17.1%) |
| Mar 2022 | - | $10.35 M(-14.9%) |
| Dec 2021 | $12.16 M(+83.5%) | $12.16 M(-13.4%) |
| Nov 2021 | - | $14.05 M(+111.9%) |
| Aug 2021 | $6.63 M(+209.5%) | $6.63 M(-34.1%) |
| May 2021 | - | $10.05 M(-6.1%) |
| Feb 2021 | - | $10.71 M(+44.9%) |
| Nov 2020 | - | $7.39 M(+244.9%) |
| Aug 2020 | $2.14 M | $2.14 M(+67.4%) |
| May 2020 | - | $1.28 M(-35.5%) |
| Feb 2020 | - | $1.98 M(-41.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2019 | - | $3.37 M(-23.7%) |
| Aug 2019 | $4.42 M(+1211.2%) | $4.42 M(+1444.7%) |
| May 2019 | - | $286.40 K(-37.4%) |
| Feb 2019 | - | $457.30 K(+297.3%) |
| Nov 2018 | - | $115.10 K(-65.9%) |
| Aug 2018 | $337.40 K(-41.1%) | $337.40 K(+3.5%) |
| May 2018 | - | $326.00 K(-37.9%) |
| Feb 2018 | - | $525.10 K(+27.3%) |
| Nov 2017 | - | $412.40 K(-28.0%) |
| Aug 2017 | $572.80 K(>+9900.0%) | $572.80 K(+151.4%) |
| May 2017 | - | $227.80 K(+1989.9%) |
| Feb 2017 | - | $10.90 K(+202.8%) |
| Nov 2016 | - | $3600.00(0.0%) |
| Aug 2016 | $3600.00(-78.8%) | $3600.00(0.0%) |
| May 2016 | - | $3600.00(0.0%) |
| Feb 2016 | - | $3600.00(-10.0%) |
| Nov 2015 | - | $4000.00(-76.5%) |
| Aug 2015 | $17.00 K(+15.6%) | $17.00 K(+34.9%) |
| May 2015 | - | $12.60 K(+55.6%) |
| Feb 2015 | - | $8100.00(-44.9%) |
| Aug 2014 | $14.70 K | $14.70 K |
FAQ
- What is Artelo Biosciences annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Artelo Biosciences?
- What is Artelo Biosciences quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Artelo Biosciences?
- What is Artelo Biosciences quarterly cash and cash equivalents year-on-year change?
What is Artelo Biosciences annual cash & cash equivalents?
The current annual cash & cash equivalents of ARTL is $2.81 M
What is the all time high annual cash & cash equivalents for Artelo Biosciences?
Artelo Biosciences all-time high annual cash & cash equivalents is $12.16 M
What is Artelo Biosciences quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ARTL is $4.36 M
What is the all time high quarterly cash and cash equivalents for Artelo Biosciences?
Artelo Biosciences all-time high quarterly cash and cash equivalents is $14.05 M
What is Artelo Biosciences quarterly cash and cash equivalents year-on-year change?
Over the past year, ARTL quarterly cash and cash equivalents has changed by +$1.54 M (+54.78%)